Intercept Pharmaceuticals, Inc.

ROYAL BANK OF CANADA

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

6,372

Value ($000)

118

Weight

0.0%

2014 Q1 - 2023 Q3 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	118	0.0%	6,372	9/30/2023
2023 Q2	8/14/2023	33	0.0%	2,965	6/30/2023
2023 Q1	5/15/2023	112	0.0%	8,378	3/31/2023
2022 Q4	2/14/2023	161	0.0%	13,027	12/31/2022
2022 Q3	11/14/2022	147	0.0%	10,537	9/30/2022
2022 Q2	8/15/2022	144	0.0%	10,373	6/30/2022
2022 Q1	5/16/2022	191	0.0%	11,768	3/31/2022
2021 Q4	2/14/2022	281	0.0%	17,313	12/31/2021
2021 Q3	11/15/2021	206	0.0%	13,884	9/30/2021
2021 Q2	8/16/2021	1,602	0.0%	80,192	6/30/2021
2021 Q1	7/20/2021	1,780	0.0%	77,102	3/31/2021
2020 Q4	2/16/2021	1,883	0.0%	76,212	12/31/2020
2020 Q3	11/16/2020	3,256	0.0%	78,538	9/30/2020
2020 Q2	8/14/2020	5,250	0.0%	109,567	6/30/2020
2020 Q1	6/16/2020	7,542	0.0%	119,788	3/31/2020
2019 Q4	2/14/2020	16,274	0.0%	131,322	12/31/2019
2014 Q1	5/15/2014	181	0.0%	550	3/31/2014